Key result
This editorial highlights that sinus node dysfunction and atrial fibrillation share a common underlying pathophysiology driven by atrial structural remodeling and fibrosis.
Answers are grounded in this paper and cite their sources.
This editorial highlights the shared pathophysiological mechanisms, particularly atrial myopathy and fibrosis, underlying both sinus node dysfunction and atrial fibrillation.
This editorial refers to ‘Sinus node dysfunction in atrial fibrillation patients: the evidence of regional atrial substrate remodelling’ by H.-Y. Chang et al., on page 205–211 The original description of the sinus node by Arthur Keith over a century ago outlined a small structure at the junction of the superior vena cava (SVC) and the right atrium (RA). Intraoperative and clinical mapping studies indicate that the ‘functional’ pacemaker actually encompasses a much larger region of posterolateral RA. This pacemaker complex extends from the SVC-RA junction inferiorly along the long axis of the crista terminalis virtually to the inferior vena cava (IVC)-RA junction.1 This complex was shown to be multi-centric, often demonstrating two or occasionally three sites of virtually simultaneous activation and exit to the atria. Physiological influences can alter the position of the lead pacemaker region, which shows cranial shift under sympathetic influence and caudal shift when the vagus predominates. Thus, there is considerable redundancy in the sino-atrial (SA) pacemaker complex, which may hold evolutionary advantages, an observation underscored by studies demonstrating that extensive ablation is required to affect sinus node function in the normal atrium.2 Recent high-density mapping studies have demonstrated the presence of preferential pathways of conduction between the sinus node and the exit of sinus activity to the atria.3 Although the location of the pacemaker region can vary, the gradual decrease in membrane potential that produces pacemaker activity is the result of several ionic currents. There is a debate regarding the relative importance, but it is generally accepted that certain currents are significant. After the action potential, the inward rectifier current (IKr and IKs) decays and this allows other inward currents to depolarize the myocyte. The inward ‘funny current’ (If), via a hyperpolarization-activated cyclic-nucleotide (HCN) channel, is well described and predominates initially and is probably a major component of the ‘membrane clock’. Inward calcium (through both T- and L-type channels) and sodium currents contribute in mid-diastole. Late in diastole, intracellular calcium release from the sarcoplasmic reticulum further promotes depolarization through the sodium/calcium exchange transporter and has been termed as the ‘calcium clock’. Recently, Chandler et al.4 comprehensively characterized the expression of over 120 ion channels and associated proteins within the human sinus node and RA. Regional differences in ion channel expression were found as expected, but using a model comprising only nine types of ion channels and three calcium handling proteins, an accurate simulation of pacemaker action potential was produced. The paranodal area was also investigated and uniquely high potassium channel expression found implying that it is depolarized relative to the RA. This may electrotonically depolarize the nearby RA and facilitate rapid conduction from the SA node. High potassium channel expression and relative depolarization may also lead to electrical instability in the paranodal region and contribute to supraventricular arrhythmias including cristal atrial tachycardias. Sinus node disease and atrial fibrillation account for a significant healthcare burden. The former takes a variety of forms including sinus bradycardia, sinus pauses, and tachy-brady syndrome and is a common indication for transvenous pacemaker implantation. The clinical association of the two diseases has long been recognized and reflects that both diseases are associated with atrial structural remodelling. Even before the development of atrial arrhythmias, patients with other conditions associated with atrial remodelling and atrial stretch may demonstrate significant sinus node dysfunction. Thus, studies in atrial and sinus node remodelling in heart failure, hypertension, and ageing have shown caudal shift of the pacemaker focus and loss of redundancy associated with low voltage and conduction slowing.5–7 In patients who have developed atrial flutter or atrial fibrillation, similar and often more advanced atrial and sinus node remodelling has been observed.8,9 A prior study by Sanders et al. investigated the nature of atrial and sinus node remodelling in patients with advanced sinus node dysfunction. In that study, a widespread atrial myopathy with areas of low voltage and slowed conduction both along the length of the crista terminalis and throughout the RA was observed.10 The study advanced the concept that a primary underlying myopathy results in both sinus node dysfunction and atrial arrhythmias. The electro-anatomic mapping study by Chang and colleagues in this issue of the Journal elegantly advances these observations. In this study, patients with atrial fibrillation and a lesser degree of sinus node dysfunction demonstrated a more regional remodelling process focused predominantly in the sinus node region.11 One important underlying correlate to these clinical electrophysiological observations is the development of fibrosis.12 In a variety of cardiovascular diseases including heart failure, hypertension, or structural heart disease, atrial stretch is a common outcome. Fibrocytes are widely distributed throughout the atrial myocardium and produce collagen in response to stretch and signalling molecules including angiotensin II and tumour growth factor β1. Protein fibril deposition replaces the normal myocardial architecture and disrupts cell–cell coupling, leading to heterogeneous conduction slowing thereby creating the substrate for arrhythmia. Fibrosis around the sinus node might slow down and block the exit of the sinus node impulse or directly disrupt pacemaker function. Direct recordings of sinus node potentials in patients with sinus node disease suggest exit block to be more common than loss of automatic behaviour.13 It seems probable that a common mechanism for both sinus node dysfunction and atrial fibrillation in conditions of atrial stretch is the development of an atrial myopathy with fibrosis and scar formation. However, beyond fibrosis other mechanisms involved in sinus node disease are gradually being elucidated as the molecular mechanisms of normal pacemaker function become clearer. The discovery of rare familial variants of sinus node disease, e.g. due to HCN4, SCN5A, or connexin mutations has been enlightening and here also a strong association with atrial fibrillation is evident.14 Atrial tachyarrhythmia itself may directly influence ion channels responsible for sinus node function. In this context, dogs treated with 7 days of atrial tachy-pacing showed reduced expression of ion channels and in particular HCN2/4 subunits responsible for the funny current.15 Importantly, clinical studies have shown that to a significant degree, sinus node dysfunction may improve within months after successful ablation of atrial flutter or atrial fibrillation.16,17 Such reverse remodelling no doubt supports the influence of reversible factors beyond atrial fibrosis. Improved understanding of sinus node physiology and the various mechanisms underlying dysfunction may facilitate the development of novel treatments for sinus node disease. In the future we may look to such advances as the design of biological pacemakers or development of therapies to repair the intrinsic sinus node. However, in the first instance, the study by Chang et al., and earlier studies of atrial and sinus node remodelling, emphasize on the important role of ‘upstream intervention’ to prevent progression to irreversible atrial fibrosis. Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2012) conducted an editorial in Sinus node dysfunction and atrial fibrillation. This editorial highlights that sinus node dysfunction and atrial fibrillation share a common underlying pathophysiology driven by atrial structural remodeling and fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: